Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL

Conditions: Multiple Myeloma; Primary Plasma Cell Leukemia Interventions: Biological: CT071 Sponsors: CARsgen Therapeutics Co., Ltd. Not yet recruiting

Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials